mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines-Reference-Cited by-同舟云学术

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines

Published:2008-06 Issue:4 Volume:13 Page:510-517
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

SHIMIZU Junichi,HORIO Yoshitsugu,OSADA Hirotaka,HIDA Toyoaki,HASEGAWA Yoshinori,SHIMOKATA Kaoru,TAKAHASHI Takashi,SEKIDO Yoshitaka,YATABE Yasushi

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2008.01302.x/fullpdf

Reference44 articles.

1. Attributable and absolute risk of lung cancer death by smoking status: Findings from the Japan collaborative cohort study

2. Cancer Statistics, 2007

3. Lung cancer

4. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

5. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma;Scientific Reports;2021-06-29

2. Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1;Oncotarget;2017-07-21

3. Chemotherapy Resistance in Lung Cancer;Lung Cancer and Personalized Medicine;2015-12-15

4. Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review;Current Medicinal Chemistry;2014-06-01

5. Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer;Tumor Biology;2014-05-12